| Value | ₹49.36 Cr |
|---|
BSE filing, NSE: SERIND. Summary written from the filing by ALFA Finder's alert engine.
Desi Farms India Ltd: key numbers
- Share price
- ₹614.55
- Market cap
- ₹60.82 Cr
- Revenue (annual)
- ₹0.55 Cr
- Net profit (annual)
- ₹0.00 Cr
- P/E (TTM)
- -195.4×Sector 27.7×
- Promoter holding
- 59.77%+4.47% QoQ
- FII holding
- 6.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Desi Farms India Ltd
All →Desi Farms India Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2026.
Desi Farms India Annual General Meeting
Desi Farms India Limited conducted its 63rd Annual General Meeting on September 30, 2026. Key agenda items included adopting financial statements and approving various related party transactions.
Desi Farms India Other Announcement
Desi Farms India dispatched a KYC reminder letter to physical security holders per SEBI circular. No financial or operational impact arises from this compliance notice.
Desi Farms India Annual General Meeting
Desi Farms India Ltd issued a corrigendum to its 63rd AGM notice. It provides additional disclosure regarding related party transactions to be approved.
Desi Farms India Other Announcement
Desi Farms India Limited has updated its official website domain name to www.desifarmsindia.org, effective immediately, from the previous domain www.ser-industries.co.in.
Desi Farms India Annual General Meeting
Desi Farms India Limited scheduled its 63rd Annual General Meeting for September 30, 2026. The agenda includes ordinary business and approval for related party transactions.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.